We stand in security lines at the airport because of the actions of a few!
We lock our doors at night because of the actions of a few!
We pay increased taxes because of the actions of a few!
We have lost many freedoms and liberties because of the actions of a few!
We have high insurance rates because of the actions of a few!
We have lots of knee-jerk legislation because of the actions of a few!
We have hot water heaters that burn up because of the actions of a few!
We flush our toilets 2 to 3 times because of the actions of a few!
We can't carry our guns anywhere we want because of the actions of a few!
We can't even carry our knives anywhere we want because of the actions of a few!
We have difficulty getting loans because of the actions of a few!
We have difficulty cashing checks because of the actions of a few!
We are wary of credit cards because of the actions of a few!
We can't share information because of the actions of a few!
We are seeing the Internet being ruined because of the actions of a few!
We have some safe and effective drugs being taken away because of the actions of a few!
We have some unsafe and ineffective drugs on the market because of the actions of a few!
We have the FDA, Senators, Representatives, and national organizations on the backs of
  compounders because of the actions of a few!

IF YOU ARE ONE OF THE FEW, think about what you are doing to the rest of us!!!!!

Loyd V. Allen, Jr., Ph.D., R.Ph
Editor-in-Chief

Don't Forget! Submit Your USP Chapter <797> Comments
Please remember to review the new draft of USP Chapter <797> (sterile compounding) and submit your comments to the United States Pharmacopeial (USP) Convention. The deadline for submitting comments is August 15, 2006. When submitting comments to USP, please send IACP a copy of your comments so we can ensure that your concerns are included in our filing. USP has several resources available to you - including a copy of the draft chapter, comment submission forms, a guidebook, webinars and more - at www.usp.org/USPNF/pf/generalChapter797.html .

Articles added to CompoundingToday.com's literature search database this week include 26 articles on the relationship of hormones and HRT to skin aging and 41 articles on miscellaneous cosmetic dermatology.

Here is a sampling:

Efficacy of 1% 4-ethoxybenzaldehyde in reducing facial erythema.
Draelos ZD, Fuller BB. Dermatol Surg 2005; 31(7 Pt 2): 881-885.

The use of sulfur in dermatology.
Gupta AK, Nicol K. J Drugs Dermatol 2004; 3(4): 427-431.

Gel vehicles are not inherently more irritating than creams.
Kirkland CR, Yelverton CB, Fleischer AB Jr et al. J Drugs Dermatol 2006; 5(3): 269-272.

Moisturizer technology versus clinical performance.
Rawlings AV, Canestrari DA, Dobkowski B. Dermatol Ther 2004; 17(Suppl 1): 49-56.

Off-label prescribing in the treatment of dermatologic disease.
Sugarman JH, Fleischer AB Jr, Feldman SR. J Am Acad Dermatol 2002; 47(2): 217-223.

Join IJPC at the First International Society of Pharmaceutical Compounding (ISPhC) Seminar held at the 66th International Congress of FIP on August 28, 2006 at Salvador Bahia, Brazil.

The 1st ISPhC Symposium will present an innovative and exciting vision of the role of quality pharmaceutical compounding in contemporary pharmacotherapy by six experienced speakers, coming from very different countries and working in different environments. They will discuss critical topics concerning pharmaceutical compounding, including the reasons and the need for compounding in modern pharmacotherapy, meeting individual patient needs through compounding, quality and regulatory issues, and the right and responsibility of the pharmacist to compound. It is important to understand the strengths and weaknesses of each country so we can learn from each other and incorporate the best practices of quality pharmaceutical compounding to better serve our patients. For details, go to www.isphc.com

P.S. Don't forget your passport and visa!

Did you know that you can search on IJPC's website 24 hours a day, 7 days a week, 365 days a year for any articles and formulas we have published over the last 10 years? Go to www.IJPC.com/editorial/SearchJournal.cfm, type in stability and see the list of all articles on stability published by IJPC you can use in your pharmacy for determining beyond-use dates. The information obtained can also help in educating local physicians.

TampAlerT Security Envelopes by EPS, INC.
The 9" x 12" TampAlerT envelope was designed to provide a maximum amount of tamper-evidence and tracking accountability for important documents, valuable patient property, confidential reports, specimens, and medical records. It's ideal for whenever you need immediate visual indication of tampering for easily transported material.

TampAlerT envelopes contain a remarkably strong closure adhesive. Once sealed, the envelopes can only be opened by cutting them. Constructed from a triple-layer extruded film, TampAlerT envelopes will immediately show visible distortion with any attempt to open them.

The detachable, serially numbered, receipt stub carries a unique coded number which is also imprinted on the body of the envelope. So you can easily match sender, recipient, and contents, ensuring security of your documents or materials. The envelopes are available in packs of just 100, with quantity pricing on as little as 5 packs. It's another smart innovation from EPS, Inc. For more information: TampAlerT Envelopes by EPS, Inc., EPS, Inc., Milton Building, 70 Industrial Drive, Ivyland, PA 18974, Phone: 800-523-8966, 215-396-8600, Fax: 800-323-8966, 215-396-6662, E-Mail: info@medidose.com, Website: www.medidose.com

Just a reminder for those who are subscribers of IJPC and a news flash to those who are not, each issue of IJPC furnishes our readers with a Standard Operating Procedure (SOP) that can be customized to your pharmacy. For example, recently released in our July/August 2006 issue was the SOP titled "Testing of Water Supply: Barnstead D4751 High Purity Water System."

Sign up today at www.IJPC.com and start your journal print and electronic subscriptions. You can download what you are currently subscribed to and purchase electronic access to our complete set of back issues.

Don't Touch That Thermostat!!!! It's up to 110�F outside!
Ever look at the storage labeling for the drug products you dispense? It may say Store at Controlled Room Temperature. This temperature is defined in the USP as "A temperature maintained thermostatically that encompasses the usual and customary working environment of 20� to 25�C (68�F to 77�F); that results in a mean kinetic temperature calculated to be not more than 25�C; and that allows for excursions between 15� and 30�C (59�F and 86�F) that are experienced in pharmacies, hospitals and warehouses." If the thermostat is turned off or even down in the winter and up in the summer, the temperature in the pharmacy may subject the drugs to temperatures outside this range. If the pharmacy is only open 9 to 6 and the thermostat turned off or changed during closed hours, then the drugs may be exposed for a long time period.